Outcome of the second Medicines Utilisation Research in Africa Group meeting to promote sustainable and appropriate medicine use in Africa.
The second Medicines Utilization Research in Africa (MURIA) group workshop and symposium again brought researchers together from across Africa to improve their knowledge of drug utilization (DU) methodologies and exchange ideas to further progress DU research in Africa. This built on extensive activities from the first conference including workshops and multiple publications. Anti-infectives were again the principal theme for the 2016 symposium following the workshops. This included presentations regarding strategies to improve antibiotic utilization among African countries, such as point-prevalence studies, as well as potential ways to reduce self-purchasing of antibiotics. There were also presentations on antiretrovirals including renal function and the impact of policy changes. Concerns with adherence in chronic treatments as well as drug-drug interactions and their implications were also discussed. The deliberations resulted in a number of agreed activities including joint publications before the next MURIA conference in Namibia in 2017.
a Department of Clinical Pharmacology, School of Medicine , University of Botswana , Gaborone , Botswana.
Amos
A
Massele
b Medicine Usage in South Africa (MUSA), Faculty of Health Sciences, School of Pharmacy , North-West University , Potchefstroom , South Africa.
Johanita
J
Burger
c School of Pharmacy , University of Namibia , Windhoek , Namibia.
Francis
F
Kalemeera
d School of Pharmacy , Catholic University of Health and Allied Sciences , Mwanza , United Republic of Tanzania.
Mary
M
Jande
e Gaborone Private Hospital , Gaborone , Botswana.
Thatayaone
T
Didimalang
f Department of Pharmacy , University of Zambia , Lusaka , Zambia.
Aubrey Chichonyi
AC
Kalungia
g Management Sciences for Health Swaziland-Mbabane , Pharmaceuticals and Health Technology Group , Mbabane , Swaziland.
Kidwell
K
Matshotyana
h University of British Columbia , Vancouver , Canada.
Michael
M
Law
i Bokamoso Private Hospital , Gaborone , Botswana.
Brighid
B
Malone
j Department of Medicine , Lagos State University Teaching Hospital - Clinical Pharmacology Unit , Ikeja , Nigeria.
Olayinka
O
Ogunleye
k Department of Pharmacology and Pharmacognosy, School of Pharmacy , University of Nairobi , Nairobi , Kenya.
Margaret
M
Oluka
l Department of Pharmacy , Nyangabgwe Hospital , Francistown , Botswana.
Bene D
BD
Paramadhas
m Department of Internal Medicine , University of Botswana , Gaborone , Botswana.
Godfrey
G
Rwegerera
n Ministry of Health and Child Welfare , Harare , Zimbabwe.
Sekesai
S
Zinyowera
o Division of Clinical Pharmacology , Karolinska Institute , Stockholm , Sweden.|p Strathclyde Institute of Pharmacy and Biomedical Sciences , University of Strathclyde , Glasgow , UK.
Brian
B
Godman
D000349:Africa; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D004363:Drug Utilization; D006801:Humans; D012106:Research / Q000458:organization & administration*
D000890:Anti-Infective Agents; D044966:Anti-Retroviral Agents
ARVs; Adherence; Africa; antibiotics; drug utilization; rational use of medicines